Medicon Hellas S.A. (ATH:MEDIC)

Greece · Delayed Price · Currency is EUR

2.880

-0.030 (-1.03%)

Last updated: Oct 8, 2026, 2:46 PM EET

Market Cap	12.73M +17.6%
Revenue (ttm)	18.63M +0.5%
Net Income	2.46M +29.8%
EPS	0.56 +29.8%
Shares Out	4.42M
PE Ratio	5.17
Forward PE	n/a
Dividend	0.13 (4.51%)
Ex-Dividend Date	Jul 13, 2026

Volume	6,002
Open	2.910
Previous Close	2.910
Day's Range	2.860 - 2.950
52-Week Range	2.320 - 3.110
Beta	0.48
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 30, 2026

About Medicon Hellas

Medicon Hellas S.A. operates in the diagnostics industry that offers instruments, tests, and procedures to clinical and research labs in Greece and internationally. It manufactures, imports, and provides diagnostic and point-of-care test systems, molecular diagnostics, laboratory automation, workflow improvement, and software solutions and services to state and private hospitals and laboratories. The company also produces and exports clinical chemistry, hematology, and immunochemistry reagents. In addition, it offers analyzers, reagents, contro... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1988

Employees 148

Stock Exchange Athens Stock Exchange

Ticker Symbol MEDIC

Full Company Profile

Financial Performance

In 2025, Medicon Hellas's revenue was 17.95 million, a decrease of -0.94% compared to the previous year's 18.12 million. Earnings were 1.73 million, an increase of 26.81%.

Financial Statements